Jacobs Levy Equity Management’s Phibro Animal Health PAHC Stock Holding History

Jacobs Levy Equity Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Sell	33,024 -80,994	-71%	-$3.42M	﹤0.01%	701
2026 Q1	$6.31M	Sell	114,018 -36,237	-24%	-$1.72M	0.03%	378
2025 Q4	$5.61M	Sell	150,255 -5,046	-3%	-$205K	0.02%	385
2025 Q3	$6.28M	Sell	155,301 -89,679	-37%	-$2.96M	0.03%	378
2025 Q2	$6.26M	Sell	244,980 -48,763	-17%	-$1.06M	0.02%	387
2025 Q1	$6.27M	Sell	293,743 -7,430	-2%	-$166K	0.02%	413
2024 Q4	$6.32M	Buy	301,173 +108,918	+57%	+$2.52M	0.02%	384
2024 Q3	$4.33M	Buy	192,255 +103,491	+117%	+$2M	0.02%	466
2024 Q2	$1.49M	Buy	88,764 +9,097	+11%	+$146K	0.01%	660
2024 Q1	$1.03M	Buy	79,667 +28,584	+56%	+$343K	﹤0.01%	710
2023 Q4	$592K	Buy	+51,083	New	+$577K	﹤0.01%	804

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jacobs Levy Equity Management's PAHC Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Phibro Animal Health (PAHC) stake by 71% in Q2 2026, selling an estimated $3.42M and leaving 33,024 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Jacobs Levy Equity Management first reported a position in PAHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.32M in Q4 2024. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Jacobs Levy Equity Management held 33,024 shares of Phibro Animal Health worth $1.04M as of Q2 2026.
Jacobs Levy Equity Management sold 80,994 Phibro Animal Health shares in Q2 2026, an estimated $3.42M.
Phibro Animal Health made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #701 holding.
Jacobs Levy Equity Management first reported a position in Phibro Animal Health in Q4 2023 and has held it in 11 quarters since.
Jacobs Levy Equity Management's Phibro Animal Health position peaked at $6.32M in Q4 2024.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.